Frequently Asked Questions:
The COVID-19 pandemic also impacted the global H2-receptor antagonists market, resulting in an XX% drop in revenue in 2020.
In 2021, North America held the major revenue share of the global H2-receptor antagonists market.
The rising prevalence of gastrointestinal disorders, growing awareness about the benefits of using H2-receptor antagonists, and increasing preference for over-the-counter (OTC) drugs are driving global market growth.
The ranitidine segment had a major global market revenue share in 2021.
In 2021, the peptic ulcer segment had a major global market revenue share.